Latest Insider Transactions at Mimedx Group, Inc. (MDXG)
This section provides a real-time view of insider transactions for Mimedx Group, Inc. (MDXG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MIMEDX GROUP, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MIMEDX GROUP, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 28
2021
|
Peter M Carlson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,274
-3.13%
|
$159,288
$12.26 P/Share
|
|
Jul 28
2021
|
Peter M Carlson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,212
+7.67%
|
-
|
|
Jul 27
2021
|
Mark Graves SVP & Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,505
-1.51%
|
$18,060
$12.07 P/Share
|
|
Jun 08
2021
|
Timothy R Wright Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
101,957
-7.13%
|
-
|
|
May 27
2021
|
James L Bierman Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,056
+17.32%
|
$170,560
$10.26 P/Share
|
|
May 27
2021
|
M Kathleen Behrens Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,056
+17.32%
|
$170,560
$10.26 P/Share
|
|
May 27
2021
|
Phyllis Gardner Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,056
+31.28%
|
$170,560
$10.26 P/Share
|
|
May 27
2021
|
Michael J Giuliani Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,056
+25.22%
|
$170,560
$10.26 P/Share
|
|
May 27
2021
|
William A Hawkins Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,056
+19.01%
|
$170,560
$10.26 P/Share
|
|
May 27
2021
|
Cato T Laurencin Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,056
+25.22%
|
$170,560
$10.26 P/Share
|
|
May 27
2021
|
Todd Newton Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,056
+17.32%
|
$170,560
$10.26 P/Share
|
|
May 01
2021
|
William Lawrence Phelan Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,433
-5.57%
|
$48,897
$9.7 P/Share
|
|
Apr 28
2021
|
Phyllis Gardner Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,423
+33.33%
|
$204,230
$10.71 P/Share
|
|
Apr 26
2021
|
Scott M Turner SVP, Operations & Procurement |
SELL
Payment of exercise price or tax liability
|
Direct |
5,224
-2.82%
|
$52,240
$10.63 P/Share
|
|
Apr 26
2021
|
Mark Graves SVP & Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,467
-3.36%
|
$34,670
$10.63 P/Share
|
|
Mar 04
2021
|
Timothy R Wright Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
335,153
+19.0%
|
-
|
|
Mar 04
2021
|
Peter M Carlson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
109,235
+21.93%
|
-
|
|
Mar 04
2021
|
Robert Benjamin Stein President, Regenerative Med. |
BUY
Grant, award, or other acquisition
|
Direct |
109,235
+36.37%
|
-
|
|
Mar 04
2021
|
William Frank Iv Hulse General Counsel and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
99,304
+32.12%
|
-
|
|
Mar 04
2021
|
Rohit Kashyap President, WC & Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
99,304
+26.7%
|
-
|
|
Mar 04
2021
|
William Lawrence Phelan Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,791
+23.39%
|
-
|
|
Mar 04
2021
|
Scott M Turner SVP, Operations & Procurement |
BUY
Grant, award, or other acquisition
|
Direct |
39,721
+17.63%
|
-
|
|
Mar 04
2021
|
Mark Graves SVP & Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,308
+20.92%
|
-
|
|
Feb 22
2021
|
Scott M Turner SVP, Operations & Procurement |
SELL
Payment of exercise price or tax liability
|
Direct |
1,572
-1.07%
|
$14,148
$9.98 P/Share
|
|
Feb 18
2021
|
Timothy R Wright Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
70,200
-6.03%
|
$631,800
$9.81 P/Share
|
|
Feb 18
2021
|
Scott M Turner SVP, Operations & Procurement |
SELL
Payment of exercise price or tax liability
|
Direct |
5,278
-3.46%
|
$47,502
$9.81 P/Share
|
|
Feb 18
2021
|
Mark Graves SVP & Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,060
-5.08%
|
$36,540
$9.81 P/Share
|
|
Feb 18
2021
|
Peter M Carlson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,015
-6.05%
|
$162,135
$9.81 P/Share
|
|
Feb 18
2021
|
William Frank Iv Hulse General Counsel and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,231
-8.47%
|
$92,079
$9.81 P/Share
|
|
Dec 16
2020
|
William A Hawkins Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,964
+22.3%
|
$111,748
$7.83 P/Share
|
|
Dec 16
2020
|
Michael J Giuliani Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,523
+37.5%
|
$234,661
$7.83 P/Share
|
|
Dec 16
2020
|
Cato T Laurencin Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,523
+37.5%
|
$234,661
$7.83 P/Share
|
|
Nov 04
2020
|
Peter M Carlson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,211
+10.58%
|
$246,477
$7.23 P/Share
|
|
Nov 04
2020
|
William Lawrence Phelan Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,474
+11.11%
|
$59,318
$7.23 P/Share
|
|
Oct 26
2020
|
Scott M Turner SVP, Operations & Procurement |
SELL
Payment of exercise price or tax liability
|
Direct |
301
-0.2%
|
$1,505
$5.91 P/Share
|
|
Oct 02
2020
|
M Kathleen Behrens Director |
BUY
Grant, award, or other acquisition
|
Direct |
26,236
+28.96%
|
$157,416
$6.67 P/Share
|
|
Oct 02
2020
|
James L Bierman Director |
BUY
Grant, award, or other acquisition
|
Direct |
26,236
+28.96%
|
$157,416
$6.67 P/Share
|
|
Oct 02
2020
|
Charles Robert Evans Director |
BUY
Grant, award, or other acquisition
|
Direct |
26,236
+17.78%
|
$157,416
$6.67 P/Share
|
|
Oct 02
2020
|
William A Hawkins Director |
BUY
Grant, award, or other acquisition
|
Direct |
26,236
+39.82%
|
$157,416
$6.67 P/Share
|
|
Oct 02
2020
|
Charles E Koob Director |
BUY
Grant, award, or other acquisition
|
Indirect |
26,236
+1.8%
|
$157,416
$6.67 P/Share
|
|
Oct 02
2020
|
Todd Newton Director |
BUY
Grant, award, or other acquisition
|
Direct |
26,236
+28.96%
|
$157,416
$6.67 P/Share
|
|
Oct 02
2020
|
Neil Yeston Director |
BUY
Grant, award, or other acquisition
|
Direct |
26,236
+17.19%
|
$157,416
$6.67 P/Share
|
|
Jul 06
2020
|
William Lawrence Phelan Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,474
+7.77%
|
$42,370
$5.4 P/Share
|